Loading...

BPLPHARMA Bharat Parenterals Ltd US FDA Inspection Announcement

Bhrt

BPLP

Bharat Parenterals Ltd

(BPLPHARMA)

2026 Announcement

Regulatory compliance

Audited Financial Results

Q4 FY26 Earnings Call

Earnings call recording

Investor Presentation

Auditor Re-appointment

Final dividend declared

Dividend declaration

Audited results and dividend

Audited results & dividend

Regulatory disclosure

Share transfer window

Price Movement Clarification

Share transfer window

Regulatory Compliance

Trading Window Closure

Regulatory Compliance Update

Unaudited Financial Results

Investor Presentation

Financial results

Board Meeting Outcome

Share transfer window

Regulatory Compliance

Regulatory disclosure

Regulatory update

Regulatory Disclosure

Appointment of Senior Manag...

Regulatory Compliance

Trading Window Closure

Share Transfer Window

Regulatory compliance

Regulatory Update

EU GMP inspection clearance

Analyst & Investor Meetings

SEBI Special Window Re-lodg...

Regulatory Compliance

Earnings Call Transcript

Newspaper advertisements fo...

Earnings call audio

Insider Trading Code

Unaudited results

Investor Presentation

Unaudited results

Investor Meeting

Earnings Call Scheduled

Transfer Deed Notice

Board Meeting Notice

Compliance Certificate

Annual General Meeting

Annual Report Access

AGM Announcement

Financial Results Published

FDA Inspection Report

Investor Presentation

New Auditors Appointed

Re-Appointment of Director

Management Change

Director Resignation

Compliance Confirmation

Investor Meet Scheduled

Annual Compliance Report

Earnings Call Summary

Earnings Call Recording

Financial Results Published

FY25 Financial Results

Appointment of Auditors

Fund Utilization Report

Earnings Call Scheduled

Earnings Conference Call

FDA Inspection Completion

Acquisition Update

Management Contact Update

Management Change

New Appointment

Compliance Update

Financial Results Published

No Fund Deviation

Large Order Secured

Company Secretary Resignation

Compliance Confirmation

Out-Licensing Deals

Share Swap Announcement

Share Swap Transaction

Equity Share Swap

Equity Shares Swap

Share Acquisition

Equity Share Allotment

Postal Ballot Notice

E-Voting Notice

Financial Results

Equity Allotment

Compliance Certificate

Postal Ballot Notice

New Auditors Appointed

Equity Share Issue

Financial Results Publication

Resignation of Auditors

Meeting Intimation

Financial Results for Q1FY25

Certificate Confirmation

Acquisition Announcement

AGM Notice Publication

E-Voting Cut Off Date

Acquisition of Shares

Acquisition of Shares

Equity Shares Allotment

Acquisition Announcement

Compliance Submission

Publication of Financial Re...

Investor Presentation

Financial Update

Revision Notice

Board Meeting Outcome

Compliance Certificate Subm...

Compliance Certificate

Certificate Submission

Resignation Announcement

Update about Subsidiary Com...

Investor Meeting

Meeting Schedule

Analyst/Investor Meeting

Investor Presentation

Financial Results Publication

Confirmation Certificate

Clarification Request - Sig...

Financial Results

Confirmation Certificate Su...

Appointment of Company Secr...

Resignation of Company Secr...

Equity Allotment

AGM Notice Publication

Financial Statements

Other Special Situation

Changes in Accounting Pract...

Annual General Meeting

External Links:

Data:

Five U.S. FDA observations (VAI) at Innoxel Lifesciences’ sterile injectables facility; Bharat Parenterals will respond within timelines as the EIR is awaited, signaling ongoing regulatory focus.

AI Assistant

Bharat Parenterals Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.